Dec 01, 2025
138:137
For every 137 shares held, investors received 138. The price per share adjusted from $0.03 to $0.03.
The split itself did not change the total investment value.
Nexalis Therapeutics Limited (ASX:NX1) operates in the Medical distributors industry.
Nexalis Therapeutics Limited company overviewNexalis Therapeutics Limited's most recent stock split was on December 1, 2025. It was a 138-for-137 forward split, so shareholders received 138 shares for every 137 they held.
Nexalis Therapeutics Limited (ASX:NX1) has split its stock 2 times: a 205-for-199 split on December 9, 2020 and a 138-for-137 split on December 1, 2025.
Nexalis Therapeutics Limited has split its stock 2 times. This history records 2 forward splits between December 9, 2020 and December 1, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Nexalis Therapeutics Limited's 138-for-137 split on December 1, 2025, every 137 shares became 138 shares.
Nexalis Therapeutics Limited has not announced a new split in our records. Its most recent split was on December 1, 2025, less than a year ago. Companies announce splits in advance, and any new ASX:NX1 split will appear on this page.
Already premium?